Dong-A ST focuses on innovative medicines developed in-house, prescription pharmaceuticals, and the expansion of its global business.
Building on its world-class, state-of-the-art research center, completed in 2011, and a highly skilled team of researchers, Dong-A ST continues to strengthen its R&D capabilities and accelerate the development of innovative medicines for the global market.
With this strong foundation, Dong-A ST is actively expanding its presence in international markets and increasing its global exports.
Through these continued efforts, the company aims to grow beyond Korea and establish itself as a leading global pharmaceutical company.
